Donald DeGolyer

Mr. Donald W.
DeGolyer is an Independent Director at Emergent BioSolutions, Inc., a Founder at Strong Women Foundation, an Independent Director at Tyme, Inc., a Secretary & Director at Vertice Pharma UK Holdings Ltd. and a Secretary & Director at Vertice Pharma UK Intermediate Ltd. He is on the Board of Directors at Emergent BioSolutions, Inc., Xevant, Inc., Tyme, Inc., Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. and Vertice Pharma UK Intermediate Ltd. Mr. DeGolyer was previously employed as an Independent Director by Tyme Technologies, Inc., an Independent Director by HLS Therapeutics, Inc., a Chief Operating Officer by Endo Pharmaceuticals, Inc., a Chief Operating Officer by Endo International Plc, a President & Chief Executive Officer by Sandoz, Inc., a Vice Chairman by Association for Accessible Medicines, an Independent Director by HLS Therapeutics, Inc. /Old/, a Principal by Johnson & Johnson, a SVP-Managed Markets & Established Medicines by Novartis Pharmaceuticals Corp., a President-Global Therapeutics by Oxford GlycoSciences Plc, a Chief Operating Officer & Executive Vice President by ParkStone Medical Info Systems, and a Vice President-Marketing & Sales by Pfizer Inc. He also served on the board at Vertice Pharma LLC and Make-A-Wish Foundation of New Jersey.
He received his undergraduate degree from the University of Rochester and an MBA from Fairleigh Dickinson University.